Cell death-inducing DFF45-like effector b (Cideb) is present in pancreatic beta-cells and involved in palmitate induced beta-cell apoptosis

Diabetes/Metabolism Research and Reviews

Volumn 28, Issue 2, 2012, Pages 145-155

  Li, H ^a   Song, Y ^a   Zhang, L J ^b   Li, F F ^a   Gu, Y ^a   Zhang, J ^a   Dong, W P ^c   Xue, L ^a   Zhang, L Y ^a   Liu, F ^a   Wang, J ^a   Jiang, L N ^a   Ye, J ^a   Li, Q ^a  

^a FOURTH MILITARY MEDICAL UNIVERSITY   (China)

^b FOURTH MILITARY MEDICAL UNIVERSITY   (China)

^c FOURTH MILITARY MEDICAL UNIVERSITY   (China)

Author keywords

Apoptosis; Cell death inducing DFF45 like effector b (Cideb); Palmitate; Pancreatic beta cells; Triacylglycerol

Indexed keywords

CASPASE 3; CIDEB PROTEIN; ESTERASE; FATTY ACID; PALMITIC ACID; PROTEIN DFF45 EFFECTOR B; RNA; TRIACYLGLYCEROL; UNCLASSIFIED DRUG;

ANIMAL EXPERIMENT; ANIMAL TISSUE; APOPTOSIS; ARTICLE; CELL DEATH; CONTROLLED STUDY; ENZYME ACTIVITY; FEMALE; HUMAN; HUMAN TISSUE; LIPID METABOLISM; LIPID STORAGE; MALE; MOUSE; NICK END LABELING; NONHUMAN; PANCREAS ISLET BETA CELL; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN FUNCTION; RAT; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; RNA INTERFERENCE;

ANIMALS; APOPTOSIS; APOPTOSIS REGULATORY PROTEINS; B-LYMPHOCYTE SUBSETS; CELL DEATH; CELL LINE; FATTY ACIDS, NONESTERIFIED; FEMALE; HUMANS; INSULIN-SECRETING CELLS; MALE; MICE; PALMITATES; RATS;

EID: 84863022790     PISSN: 15207552     EISSN: 15207560     Source Type: Journal    
DOI: 10.1002/dmrr.1295     Document Type: Article

References (40)

1. Unger RH, Zhou YT. Lipotoxicity of beta-cells in obesity and in other causes of fatty acid spillover. Diabetes 2001; 50(Suppl 1): S118-S121.
2. Wilding JP. The importance of free fatty acids in the development of Type 2 diabetes. Diabet Med 2007; 24: 934-945.
3. Unger RH. Lipotoxic diseases. Annu Rev Med 2002; 53: 319-336.
4. Butler AE, Janson J, Bonner-Weir S, et al. Beta-cell deficit and increased beta-cell apoptosis in humans with type 2 diabetes. Diabetes 2003; 52: 102-110.
5. Johnson JD. Proteomic identification of carboxypeptidase E connects lipid-induced beta-cell apoptosis and dysfunction in type 2 diabetes. Cell Cycle 2009; 8: 38-42.
6. Gwiazda KS, Yang TL, Lin Y, et al. Effects of palmitate on ER and cytosolic Ca2+ homeostasis in beta-cells. Am J Physiol Endocrinol Metab 2009; 296: E690-E701.
7. El-Assaad W, Buteau J, Peyot ML, et al. Saturated fatty acids synergize with elevated glucose to cause pancreatic beta-cell death. Endocrinology 2003; 144: 4154-4163.
8. Inohara N, Koseki T, Chen S, et al. CIDE, a novel family of cell death activators with homology to the 45kDa subunit of the DNA fragmentation factor. EMBO J 1998; 17: 2526-2533.
9. Liang L, Zhao M, Xu Z, et al. Molecular cloning and characterization of CIDE-3, a novel member of the cell-death-inducing DNA-fragmentation-factor (DFF45)-like effector family. Biochem J 2003; 370: 195-203.
10. Chen Z, Guo K, Toh SY, et al. Mitochondria localization and dimerization are required for CIDE-B to induce apoptosis. J Biol Chem 2000; 275: 22619-22622.
11. Kim JY, Liu K, Zhou S, et al. Assessment of fat-specific protein 27 in the adipocyte lineage suggests a dual role for FSP27 in adipocyte metabolism and cell death. Am J Physiol Endocrinol Metab 2008; 294: E654-E667.
12. Erdtmann L, Franck N, Lerat H, et al. The hepatitis C virus NS2 protein is an inhibitor of CIDE-B-induced apoptosis. J Biol Chem 2003; 278: 18256-18264.
13. Liu K, Zhou S, Kim JY, et al. Functional analysis of FSP27 protein regions for lipid droplet localization, caspase-dependent apoptosis, and dimerization with CIDEA. Am J Physiol Endocrinol Metab 2009; 297: E1395-E1413.
14. Inohara N, Nunez G. Genes with homology to DFF/CIDEs found in Drosophila melanogaster. Cell Death Differ 1999; 6: 823-824.
15. Lugovskoy AA, Zhou P, Chou JJ, et al. Solution structure of the CIDE-N domain of CIDE-B and a model for CIDE-N/CIDE-N interactions in the DNA fragmentation pathway of apoptosis. Cell 1999; 99: 747-755.
16. Lechardeur D, Dougaparsad S, Nemes C, et al. Oligomerization state of the DNA fragmentation factor in normal and apoptotic cells. J Biol Chem 2005; 280: 40216-40225.
17. Bayascas JR, Yuste VJ, Sole C, et al. Characterization of splice variants of human caspase-activated DNase with CIDE-N structure and function. FEBS Lett 2004; 566: 234-240.
18. Gong J, Sun Z, Li P. CIDE proteins and metabolic disorders. Curr Opin Lipidol 2009; 20: 121-126.
19. Ito M, Nagasawa M, Hara T, et al. Differential roles of CIDEA and CIDEC in insulin-induced anti-apoptosis and lipid droplet formation in human adipocytes. J Lipid Res 2010; 51: 1676-1684.
20. Yonezawa T, Haga S, Kobayashi Y, et al. Saturated fatty acids stimulate and insulin suppresses CIDE-A expression in bovine mammary epithelial cells. Biochem Biophys Res Commun 2009; 384: 535-539.
21. Hall AM, Brunt EM, Klein S, et al. Hepatic expression of cell death-inducing DFFA-like effector C in obese subjects is reduced by marked weight loss. Obesity (Silver Spring) 2010; 18: 417-419.
22. Puri V, Ranjit S, Konda S, et al. Cidea is associated with lipid droplets and insulin sensitivity in humans. Proc Natl Acad Sci USA 2008; 105: 7833-7838.
23. Li JZ, Ye J, Xue B, et al. Cideb regulates diet-induced obesity, liver steatosis, and insulin sensitivity by controlling lipogenesis and fatty acid oxidation. Diabetes 2007; 56: 2523-2532.
24. Ye J, Li JZ, Liu Y, et al. Cideb, an ER- and lipid droplet-associated protein, mediates VLDL lipidation and maturation by interacting with apolipoprotein B. Cell Metab 2009; 9: 177-190.
25. Li JZ, Lei Y, Wang Y, et al. Control of cholesterol biosynthesis, uptake and storage in hepatocytes by Cideb. Biochim Biophys Acta 2010; 1801: 577-586.
26. Livak KJ, Schmittgen TD. Analysis of relative gene expression data using real-time quantitative PCR and the 2(-Delta Delta C(T)) Method. Methods 2001; 25: 402-408.
27. Li Q, Zhang XQ, Nie L, et al. Expression of interferon-gamma in human adrenal gland and kidney tumours. Br J Cancer 2007; 97: 420-425.
28. Shen L, Liu X, Hou W, et al. NDRG2 is highly expressed in pancreatic beta cells and involved in protection against lipotoxicity. Cell Mol Life Sci 2010; 67: 1371-1381.
29. Wang XL, Zhang L, Youker K, et al. Free fatty acids inhibit insulin signaling-stimulated endothelial nitric oxide synthase activation through upregulating PTEN or inhibiting Akt kinase. Diabetes 2006; 55: 2301-2310.
30. Li F, Gu Y, Dong W, et al. Cell death-inducing DFF45-like effector, a lipid droplet-associated protein, might be involved in the differentiation of human adipocytes. FEBS J 2010; 277: 4173-4183.
31. Hong L, Zhang J, Min J, et al. A role for MHBst167/HBx in hepatitis B virus-induced renal tubular cell apoptosis. Nephrol Dial Transplant 2010; 25: 2125-2133.
32. Li H, Song Y, Li F, et al. Identification of lipid droplet-associated proteins in the formation of macrophage-derived foam cells using microarrays. Int J Mol Med 2010; 26: 231-239.
33. Borg J, Klint C, Wierup N, et al. Perilipin is present in islets of Langerhans and protects against lipotoxicity when overexpressed in the beta-cell line INS-1. Endocrinology 2009; 150: 3049-3057.
34. Urahama Y, Ohsaki Y, Fujita Y, et al. Lipid droplet-associated proteins protect renal tubular cells from fatty acid-induced apoptosis. Am J Pathol 2008; 173: 1286-1294.
35. Newsholme P, Keane D, Welters HJ, et al. Life and death decisions of the pancreatic beta-cell: the role of fatty acids. Clin Sci (Lond) 2007; 112: 27-42.
36. Unger RH, Orci L. Lipoapoptosis: its mechanism and its diseases. Biochim Biophys Acta 2002; 1585: 202-212.
37. Karaskov E, Scott C, Zhang L, et al. Chronic palmitate but not oleate exposure induces endoplasmic reticulum stress, which may contribute to INS-1 pancreatic beta-cell apoptosis. Endocrinology 2006; 147: 3398-3407.
38. Listenberger LL, Han X, Lewis SE, et al. Triglyceride accumulation protects against fatty acid-induced lipotoxicity. Proc Natl Acad Sci USA 2003; 100: 3077-3082.
39. Cnop M, Hannaert JC, Hoorens A, et al. Inverse relationship between cytotoxicity of free fatty acids in pancreatic islet cells and cellular triglyceride accumulation. Diabetes 2001; 50: 1771-1777.
40. Moffitt JH, Fielding BA, Evershed R, et al. Adverse physicochemical properties of tripalmitin in beta cells lead to morphological changes and lipotoxicity in vitro. Diabetologia 2005; 48: 1819-1829.